Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts
about
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlookRegulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapyRebalancing immune specificity and function in cancer by T-cell receptor gene therapy.B7-H1 expression is associated with expansion of regulatory T cells in colorectal carcinoma.Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma.Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceFolate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte ResponsesLevel of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications.Immune response to cancer and its regulation in regional lymph nodes.PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy.Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.Association of Marek's Disease induced immunosuppression with activation of a novel regulatory T cells in chickens.Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation InAdoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies
P2860
Q27004178-C8AD7C02-FC97-4DBD-BF53-052A244E57BAQ33723734-24916474-9881-441A-A660-2D28A0803A99Q34084756-1ED5D1E9-357A-47E0-9262-DCFE2AA254EAQ35813519-A6E54FF8-8E52-436F-9D44-1CE8295594CCQ36422292-0B352835-9CF9-48D2-8630-C922E422D68DQ36555546-CB58A2D0-033E-4B35-A3E4-5E4D2BFB99C3Q36723775-E633D5EA-6088-43A9-AF5E-AB4E84B82BABQ37608658-1A689A32-AC36-4FE0-A4D8-7243FDEFD990Q37863623-C56D74C0-F212-40DB-B4ED-BDC70C00BEF3Q42839507-EE63A737-24CA-43EC-B2F5-F058C6E6A055Q46235539-25350B76-7B61-4C3C-B2A7-120A679F6C50Q46248185-26EEB73B-A844-47F9-B0F3-0E1B9DDCC2FFQ47265177-E5570D94-3E5A-4966-BA2E-CF1070B2966AQ52804774-367D0070-9EDD-4C39-A6C7-885F93AF3202Q57172250-B59ED8D4-FE58-44A8-B8E3-27D3C633C38B
P2860
Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Depletion of tumor-induced Tre ...... r T cells in lymphopenic hosts
@ast
Depletion of tumor-induced Tre ...... r T cells in lymphopenic hosts
@en
type
label
Depletion of tumor-induced Tre ...... r T cells in lymphopenic hosts
@ast
Depletion of tumor-induced Tre ...... r T cells in lymphopenic hosts
@en
prefLabel
Depletion of tumor-induced Tre ...... r T cells in lymphopenic hosts
@ast
Depletion of tumor-induced Tre ...... r T cells in lymphopenic hosts
@en
P2093
P2860
P356
P1476
Depletion of tumor-induced Tre ...... r T cells in lymphopenic hosts
@en
P2093
Bernard A Fox
Christian H Poehlein
Daniel P Haley
Edwin B Walker
P2860
P304
P356
10.1002/EJI.200939453
P407
P577
2009-11-01T00:00:00Z